Tejara Capital’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-85,163
Closed -$1.45M 75
2025
Q3
$1.45M Sell
85,163
-114,987
-57% -$1.65M 0.76% 34
2025
Q2
$2.51M Buy
200,150
+10,741
+6% +$128K 1.16% 30
2025
Q1
$2.26M Buy
189,409
+150,872
+391% +$2.06M 0.87% 33
2024
Q4
$564K Buy
+38,537
New +$539K 0.37% 47
2024
Q3
Sell
-270,212
Closed -$2.3M 74
2024
Q2
$2.3M Buy
270,212
+60,000
+29% +$534K 0.84% 36
2024
Q1
$2.21M Sell
210,212
-45,363
-18% -$504K 0.81% 35
2023
Q4
$2.66M Sell
255,575
-32,518
-11% -$259K 1.11% 28
2023
Q3
$1.83M Hold
288,093
1.04% 28
2023
Q2
$2.49M Sell
288,093
-56,317
-16% -$504K 1.23% 26
2023
Q1
$3.11M Sell
344,410
-61,966
-15% -$540K 1.59% 21
2022
Q4
$3.19M Buy
+406,376
New +$2.86M 1.84% 14

Other funds holding ZYME

Tejara Capital's ZYME Position: Q4 2025 in Review

Tejara Capital sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 85,163 shares — an estimated $1.45M sold.

Tejara Capital first reported a position in ZYME in Q4 2022 and held it in 11 quarters. The position peaked at $3.19M in Q4 2022. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.

  • Tejara Capital reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
  • Tejara Capital sold 85,163 Zymeworks shares in Q4 2025, an estimated $1.45M.
  • Tejara Capital first reported a position in Zymeworks in Q4 2022 and held it in 11 quarters.
  • Tejara Capital's Zymeworks position peaked at $3.19M in Q4 2022.
  • 209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.

Based on Tejara Capital's 13F filing for Q4 2025, filed 5 Feb 2026.